Nancy A. Simonian

Biography

Nancy A. Simonian, M.D. joined the Board of Directors in March 2012. Since July 2012, Dr. Simonian has served as Chief Executive Officer of Syros Pharmaceuticals, a publicly held life science company focused on gene control therapeutics. From 2001 to 2011 she was with Millennium: The Takeda Oncology Company, most recently serving as Chief Medical Officer and Senior Vice President of Clinical, Medical and Regulatory Affairs. Before Millennium, she was Vice President of Clinical Research at Biogen (now Biogen Idec) where she was responsible for clinical development and medical affairs of the neurology and oncology pipeline, including Avonex® and Tysabri®. Dr. Simonian serves on the boards of the Biotechnology Innovation Organization and the Damon Runyan Foundation. Prior to joining the pharmaceutical industry, Dr. Simonian was on the faculty of Massachusetts General Hospital and Harvard Medical School as an assistant professor of neurology. She received a B.A. in Biology from Princeton University and an M.D. from the University of Pennsylvania Medical School.

Research Interest

Gene Control Therapeutics, Pharmaceuticals